CTOs on the Move

Variant Pharmaceuticals

www.variantpharma.com

 
Variant Pharmaceuticals is an orphan drug company leveraging advanced proprietary technologies to develop best-in-class drugs for patients with rare diseases.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Variant Pharmaceuticals raised $10M on 12/03/2018

Similar Companies

Turenne PharMedCo

Turenne PharMedCo, Inc. is a leading national healthcare service organization offering long term care pharmacy and medical supply solutions to skilled nursing and assisted living facilities, home health agencies, hospice organizations, durable/home medical equipment providers, and other healthcare-related institutions and companies nationwide.

Intelligent Implants

Intelligent Implants is a medical device company operating at the intersection of digital medicine and orthopedics. We develop innovative electrotherapeutic orthopedic devices to address significant unmet clinical needs. The company`s SmartFuse® platform is a wirelessly enabled, active implant technology that uses an array of electrodes to stimulate, control, and monitor bone growth. Our mission is to leverage SmartFuse to develop a pipeline of smart orthopedic implants that can reduce healing times, engage patients & surgeons, enable digital surgery/robotics and ultimately improve outcomes for millions of patients.

Northern Illinois Blood Bank

Northern Illinois Blood Bank is a Rockford, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fischer Medical Technologies

Fischer Medical Technologies is a Broomfield, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sanuwave

SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE`s portfolio of products and product candidates activate biologic signaling and angiogenic reponses, including revascularization and microcirculation, helping to restore the body`s normal healing processes and regeneration. These devices, based on Pulsed Acoustic Cellular Expression (PACE™) technology, are being developed and commercialized for use in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.